Skip to content
Sign in

OZEM · NASDAQ · ETF

Roundhill GLP-1 & Weight Loss ETF (OZEM) Price, Holdings & Fees

$571.70−0.57%−$3.26End-of-day price as of Oct 9, 2026

Roundhill GLP-1 & Weight Loss ETF (OZEM) closed at $571.70 on Oct 9, 2026, down 0.57% from the previous close of $574.96.

Share price, past year

1Y +34.56%

52-week range $408.21 – $582.65. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$571.70
Sep 30, 2026$572.35
Aug 31, 2026$570.74
Jul 31, 2026$542.63
Jun 30, 2026$510.96
May 29, 2026$474.92
Apr 30, 2026$466.35
Mar 31, 2026$458.25
Feb 27, 2026$450.34
Jan 30, 2026$431.83
Dec 31, 2025$429.41
Nov 28, 2025$421.40
Oct 31, 2025$425.47

Key statistics

Expense ratio
0.59%
as of Apr 30, 2026
Net assets
$54.1M
as of Jun 30, 2026
Holdings
26
as of Jun 30, 2026
52-week range
$408.21 – $582.65

Roundhill GLP-1 & Weight Loss ETF's expense ratio is 0.59%: $59.00 a year on $10,000 invested.

Holdings

Roundhill GLP-1 & Weight Loss ETF held 26 investments worth $54.08M as of Jun 30, 2026. Its largest holding was Novo Nordisk A/S, at 12.96% of the fund.

Roundhill GLP-1 & Weight Loss ETF largest holdings by share of net assets
#Holding% of fundValue
1Novo Nordisk A/SNVO12.96%$7.01M
2Eli Lilly & CoLLY12.69%$6.86M
3Mount Vernon Liquid Assets Portfolio, LLC9.93%$5.37M
4Pfizer IncPFE6.38%$3.45M
5Kailera Therapeutics IncKLRA6.21%$3.36M
6Viking Therapeutics IncVKTX5.86%$3.17M
7CSPC Pharmaceutical Group Ltd5.32%$2.88M
8Chugai Pharmaceutical Co Ltd4.51%$2.44M
9Ascletis Pharma Inc4.20%$2.27M
10Zealand Pharma A/S3.92%$2.12M
11Amgen IncAMGN3.85%$2.08M
12AstraZeneca PLCAZN3.83%$2.07M
13Hanmi Pharm Co Ltd3.50%$1.90M
14Structure Therapeutics IncGPCR3.05%$1.65M
15Roche Holding AGROP3.03%$1.64M
16MBX Biosciences IncMBX2.80%$1.51M
17UNITED LAB2.63%$1.42M
18Jiangsu Hengrui Pharmaceutical2.58%$1.40M
19Hansoh Pharmaceutical Group Co2.54%$1.37M
20Innovent Biologics Inc2.36%$1.28M
21Gubra A/S1.87%$1.01M
22Gilead Sciences IncGILD1.73%$938.07K
23Rhythm Pharmaceuticals IncRYTM1.64%$884.46K
24Shionogi & Co Ltd1.24%$670.97K
25WaVe Life Sciences LtdWVE0.86%$467.31K

Top 25 of 26 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.

What the fund owns

Roundhill GLP-1 & Weight Loss ETF holdings by asset type
Asset type% of fund
Stocks99.59%
Cash and short-term investments10.55%
Roundhill GLP-1 & Weight Loss ETF holdings by country, largest 9
Country% of fund
United States54.77%
Denmark18.76%
China17.00%
Japan5.75%
United Kingdom3.83%
South Korea3.50%
Switzerland3.03%
Hong Kong2.63%
Singapore0.86%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jun 30, 2026, Roundhill GLP-1 & Weight Loss ETF's total return was +4.50%, as reported to the SEC.

Roundhill GLP-1 & Weight Loss ETF monthly total returns
MonthTotal return
Jun 30, 2026+2.02%
May 31, 2026+2.40%
Apr 30, 2026+0.03%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Roundhill GLP-1 & Weight Loss ETF
Ticker
OZEM
Exchange
NASDAQ
Fund type
ETF
Trust
Roundhill ETF Trust
SEC series ID
S000085000
SEC CIK
0001976517
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by Roundhill ETF Trust, the trust behind Roundhill GLP-1 & Weight Loss ETF, and cover all of its funds.

Frequently asked questions

What is OZEM's price?

Roundhill GLP-1 & Weight Loss ETF (OZEM) closed at $571.70 on Oct 9, 2026, down 0.57% from the previous close of $574.96.

What is OZEM's expense ratio?

Roundhill GLP-1 & Weight Loss ETF's expense ratio is 0.59%: $59.00 a year on $10,000 invested.

What does OZEM hold?

Roundhill GLP-1 & Weight Loss ETF held 26 investments worth $54.08M as of Jun 30, 2026. Its largest holding was Novo Nordisk A/S, at 12.96% of the fund. Its five largest holdings were Novo Nordisk A/S, Eli Lilly & Co, Mount Vernon Liquid Assets Portfolio, LLC, Pfizer Inc, Kailera Therapeutics Inc.

How has OZEM performed?

Over the 3 months to Jun 30, 2026, Roundhill GLP-1 & Weight Loss ETF's total return was +4.50%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 26, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Apr 30, 2026. Prices are generated sample data for development. Data sources and disclosures